Cell & Gene Therapy Manufacturing & Commercialization Europe
Don’t miss this opportunity to connect with NIBRT at the Cell & Gene Therapy Manufacturing & Commercialization Europe conference in Dublin, December 4-7.
As a leader in the CGT field, NIBRT’s Principal Investigator and Director Jonathan Bones will present cutting-edge research on “Characterisation of AAV on Multiple Levels Using Liquid Phase Separations Coupled to Mass Spectrometry.”
His session will demonstrate advanced analytical techniques for characterizing adeno-associated viral vectors, providing practical solutions to pressing AAV gene therapy manufacturing challenges.
Join 400+ global CGT leaders and innovators in Cell & Gene Therapy at this premier European conference. Propelled by the latest strategies in process development, analytics, and market access – this is your opportunity to elevate your CGT programs towards commercial success.
As a valued NIBRT affiliate, you can unlock a special 10% discount by registering using the link below!
